Bladder Drug Patent Fails To Survive In Del.
A Delaware federal judge told a Japanese pharmaceutical company that its "zealous defense" of the validity of a patent covering an extended-release version of its brand-name overactive bladder medication ended up...To view the full article, register now.
Already a subscriber? Click here to view full article